Short Summary
LG Electronics and Maxell settled their inter partes review of U.S. Patent 10,244,284 B2, leading the PTAB to terminate the proceeding before a trial was instituted.
Detailed Summary
In IPR2025-00520 concerning U.S. Patent 10,244,284 B2, LG Electronics, Inc. and LG Electronics USA, Inc. filed a joint motion to terminate the inter partes review after reaching a settlement with patent owner Maxell, LTD. The PTAB, presided over by Administrative Patent Judges Kevin C. Trock, Monica S. Ullagaddi, and Jason W. Melvin, granted the motion, terminated the proceeding, and ordered the settlement agreement to be kept confidential under 37 C.F.R. § 42.74(c). No claims were instituted or adjudicated, and the case concluded without a final written decision on patent validity.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in LG Electronics, Inc. et al. vs Maxell, LTD. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
PacifiCorp et al.vsMES, Inc.
PacifiCorp and affiliates challenge the Director’s discretionary denial of their IPRs on a mercury‑control patent, arguing the petitions are timely and no third‑party interests exist. The Board is asked to deny the Director Review and keep the PTAB as the forum for validity issues.
Samsung Electronics Co., Ltd. et al.vsXiFi Networks R&D, Inc.
The Board granted institution for the IPR against XiFi Networks' patent 11849337, allowing Samsung Electronics to proceed with its challenge, though the trial is currently stayed.
Berkshire Hathaway Energy Company et al.vsMES, Inc.
Berkshire Hathaway Energy’s subsidiaries and patent owner Birchtech have settled their dispute over U.S. Patent 10,343,114. The parties filed a joint motion to terminate the inter partes review concerning WEC Energy Group, citing settlement and statutory provisions.
Abbott Laboratories et al.vsMIRACOR MEDICAL SA
The PTAB denied Abbott Laboratories' request for Director Review of the institution decisions in three IPRs, including IPR2025-00116 covering Miracor Medical's patent 11,754,077 B1. The institution decisions remain in effect.
Samsung Electronics Co., Ltd. et al.vsASUS Technology Licensing Inc.
Samsung challenges an ASUS patent regarding 5G NR power control and PHR triggering using multiple prior art references including Ericsson and Huawei. The core argument is obviousness based on predictable combinations within industry standard-setting documents.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.